• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Seres Therapeutics Inc (NQ: MCRB )

    0.8119 +0.0045 (+0.56%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Seres Therapeutics Inc

    < Previous 1 2 3 4 5 Next >
    This Verizon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q2 2024
    MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Seres Therapeutics's Earnings: A Preview
    Via Benzinga
    Earnings Outlook For Seres Therapeutics
    Via Benzinga
    Earnings Outlook For Seres Therapeutics
    Via Benzinga
    Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Looking Into Seres Therapeutics's Return On Capital Employed
    Via Benzinga
    Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q1 2024
    MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Nasdaq Down Over 50 Points; Uber Posts Q1 Loss
    Via Benzinga
    Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Gold Price Alert: Gold Spot Prices Just Hit a Record High Today
    Investors in gold are excited on Tuesday as the spot price of the precious metal hit a recent high of $2,113.28 per ounce during a rally. 
    Via InvestorPlace
    MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q4 2023
    MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Why Is Microbiome-Based Seres Therapeutics Stock Trading Higher Today?
    Seres Therapeutics Inc (NASDAQ: MCRB) received FDA Fast Track Designation for SER-155, an investigational oral, cultivated microbiome therapeutic designed to prevent GI-associated bacterial infections... 
    Via Benzinga
    Exposures Product Safety
    Earnings Scheduled For March 5, 2024
    Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
    Via Benzinga
    Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
    U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Nasdaq Gains 1%; US Adds 150,000 Jobs In October
    U.S. stocks traded higher this morning, following the release of jobs report for October. Following the market opening Friday, the Dow traded up 0.50% to 34,009.36 while the NASDAQ rose 1% to... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
    Via Benzinga
    Seres Therapeutics' Q2 Revenues Top Estimates; Reports Encouraging VOWST Early Commercial Uptake
    Seres Therapeutics, Inc. (NASDAQ: MCRB) reported Q2 revenues of $126.47 million,  
    Via Benzinga
    Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
    Via Benzinga
    'Walk Away From It': Jim Cramer On This US Telecom Service Provider
    On CNBC’s "Mad Money Lightning Round," Jim Cramer said AT&T Inc. (NYSE: T) is "as poorly managed as any company I’ve ever seen in my lifetime." He added, 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.